Literature DB >> 31647957

Commentary: Opioid use disorder and suicide: An important opportunity to address two significant public health epidemics.

Sanchit Maruti1, Isabelle Desjardins2, Courtney L Bagge3, Robert R Althoff2.   

Abstract

Nationwide, the opioid epidemic continues to have a significant and widespread adverse impact on morbidity and mortality. The number of individuals dying by suicide and unintentional overdose has continued to increase over the past decade, with opioids being involved in a significant proportion of each category of mortality in 2017. Currently, most strategies for decreasing opioid-overdose deaths do not include systematic screening for suicide risk, nor do they address the necessity to customize interventions for those who misuse opioids to decrease near-term suicide risk (defined here as less than 72 h) factors. Improved screening of near-term and chronic suicide risk along with rapid access to treatment is of critical importance to prevent opioid-related deaths by suicide.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Opioiod use disorders, OUDs; Substance use disorders, SUDs; Suicide; Suicide assessment; Suicide screening

Year:  2019        PMID: 31647957     DOI: 10.1016/j.ypmed.2019.105854

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  2 in total

1.  Patient-reported outcomes in major depressive disorder with suicidal ideation: a real-world data analysis using PatientsLikeMe platform.

Authors:  Stephane Borentain; Abigail I Nash; Rachna Dayal; Allitia DiBernardo
Journal:  BMC Psychiatry       Date:  2020-07-23       Impact factor: 4.144

2.  Reduced serum VGF levels are linked with suicide risk in Chinese Han patients with major depressive disorder.

Authors:  Xingxing Li; Huifei Ge; Dongsheng Zhou; Xiangping Wu; Gangqiao Qi; Zan Chen; Chang Yu; Yuanyuan Zhang; Haihang Yu; Chuang Wang
Journal:  BMC Psychiatry       Date:  2020-05-12       Impact factor: 3.630

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.